RaQualia Pharma Inc. (4579.T)
JPY 418.0
(0.24%)
JPY 418.0
(0.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.9 Billion | 2.91 Billion | 2.77 Billion | 1.1 Billion | 1.7 Billion | 744.51 Million |
| Cost of Revenue | 245.05 Million | 231.58 Million | 320.67 Million | 138.01 Million | 262.8 Million | 89.41 Million |
| Gross Profit | 1.65 Billion | 2.68 Billion | 2.45 Billion | 969.28 Million | 1.44 Billion | 655.1 Million |
| Operating Expenses | 1.81 Billion | 1.82 Billion | 1.74 Billion | 1.45 Billion | 1.45 Billion | 1.73 Billion |
| Selling, General and Administrative Expenses | 620.95 Million | 571.53 Million | 620.3 Million | 522.91 Million | 591.86 Million | 655.59 Million |
| Research and Development Expenses | 1.37 Billion | 1.24 Billion | 1.12 Billion | 932.45 Million | 864.25 Million | 1.07 Billion |
| Other Expenses | 1000.00 | -211 Thousand | -848 Thousand | 2.11 Million | 1.04 Million | 3.99 Million |
| Cost and Expenses | 2.23 Billion | 2.05 Billion | 2.06 Billion | 1.59 Billion | 1.71 Billion | 1.81 Billion |
| Operating Income | -337.36 Million | 866.23 Million | 707.86 Million | -486.07 Million | -25.84 Million | -1.07 Billion |
| Interest Expense | 6.68 Million | 5.99 Million | 1.45 Million | 436 Thousand | 11.76 Million | 1.4 Million |
| Income Tax Expense | 29.61 Million | 127.62 Million | 124.79 Million | 79.04 Million | 21.96 Million | 26.35 Million |
| Earnings before Tax | -294.04 Million | 851.01 Million | 880.57 Million | -527.94 Million | 27.31 Million | -1.07 Billion |
| Net Income | -323.66 Million | 723.39 Million | 755.78 Million | -606.98 Million | 5.34 Million | -1.1 Billion |
| Earnings Per Share Basic | -14.98 | 34.50 | 36.07 | -28.97 | 0.26 | -54.23 |
| Earnings Per Share Diluted | -14.98 | 34.47 | 36.04 | -28.97 | 0.26 | -54.23 |
| Weighted Average Shares Outstanding | 21.6 Million | 20.96 Million | 20.95 Million | 20.95 Million | 20.58 Million | 20.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.6 Million | 20.98 Million | 20.97 Million | 20.95 Million | 20.61 Million | 20.36 Million |
| Gross Margin | 0.87 | 0.92 | 0.88 | 0.88 | 0.85 | 0.88 |
| EBIT Margin | -0.06 | 0.36 | 0.37 | -0.36 | 0.07 | -1.26 |
| Profit Margin | -0.17 | 0.25 | 0.27 | -0.55 | 0.00 | -1.48 |
| EBITDA | -111.8 Million | 1 Billion | 1.02 Billion | -403.24 Million | 124 Million | -950 Million |
| Earnings Before Tax Margin | -0.18 | 0.30 | 0.25 | -0.44 | -0.02 | -1.44 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 762.46 Million | 648.58 Million | 405.7 Million | 1.9 Billion | 481.4 Million | 643.59 Million |
| Cost of Revenue | 212.87 Million | 105.67 Million | 110.68 Million | 420.61 Million | 67.14 Million | 62.85 Million |
| Gross Profit | 549.59 Million | 542.9 Million | 295.02 Million | 1.48 Billion | 414.26 Million | 580.74 Million |
| Operating Expenses | 748.31 Million | 498.39 Million | 524.3 Million | 1.81 Billion | 498.97 Million | 495.29 Million |
| Selling, General and Administrative Expenses | 274.66 Million | 139.38 Million | 86.18 Million | - | 167.87 Million | 160.31 Million |
| Research and Development Expenses | 473.65 Million | 359.01 Million | 438.12 Million | - | 331.09 Million | 334.97 Million |
| Other Expenses | 4.34 Million | -138.45 Million | 8.07 Million | 14.58 Million | 348 Thousand | 6.88 Million |
| Cost and Expenses | 961.19 Million | 604.06 Million | 634.99 Million | 2.23 Billion | 566.11 Million | 558.14 Million |
| Operating Income | -198.72 Million | 44.51 Million | -229.28 Million | -337.36 Million | -84.7 Million | 85.45 Million |
| Interest Expense | 13.89 Million | 1.94 Million | 2.05 Million | 6.68 Million | 1.6 Million | 1.52 Million |
| Income Tax Expense | 46.17 Million | 3.95 Million | -50.91 Million | 29.61 Million | 69.28 Million | -27.11 Million |
| Earnings before Tax | -199.57 Million | -74.15 Million | -256.93 Million | -294.04 Million | -73.82 Million | 146.73 Million |
| Net Income | -245.75 Million | -78.1 Million | -206.02 Million | -323.66 Million | -143.11 Million | 173.85 Million |
| Earnings Per Share Basic | -11.36 | -3.61 | -9.53 | - | -6.62 | 8.04 |
| Earnings Per Share Diluted | -11.36 | -3.61 | -9.53 | - | -6.62 | 8.04 |
| Weighted Average Shares Outstanding | 21.63 Million | 21.62 Million | 21.61 Million | 21.6 Million | 21.61 Million | 21.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.63 Million | 21.62 Million | 21.61 Million | 21.6 Million | 21.61 Million | 21.61 Million |
| Gross Margin | 0.72 | 0.84 | 0.73 | 0.78 | 0.86 | 0.90 |
| EBIT Margin | -0.20 | 0.14 | -0.43 | - | -0.02 | 0.34 |
| Profit Margin | -0.32 | -0.12 | -0.51 | -0.17 | -0.30 | 0.27 |
| EBITDA | -152.3 Million | 89.65 Million | -174.23 Million | - | -11.85 Million | 218.26 Million |
| Earnings Before Tax Margin | -0.26 | 0.07 | -0.57 | -0.18 | -0.18 | 0.13 |
IMOS
DWARKESH
4733
NVT
LNG
0HOT